Vaccine provides protection against particular diseases by improving immunity. Vaccines are the biological preparations of weakened or killed microorganism, its surface proteins or its toxins.
The global paediatric vaccine market is expected to grow at a healthy CAGR in next few years.
Increase in growth would be primarily attributed to improved understanding of immunology, which has resulted in launch of new vaccines products. Technological breakthrough has led to development of new vaccine class such as DNA vaccines, vector vaccines, intranasal vaccines, mucosal vaccines and others.
However, manufacturing complexity and stringent regulatory compliance are the factors that hinder the market growth. Refusal to immunization and vaccines shortages are other restraints for this market.
In 2017, the global Paediatric Vaccine market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2018. The objectives of this study are to define, segment, and project the size of the Paediatric Vaccine market based on company, product type, application and key regions.
This report studies the global market size of Paediatric Vaccine in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Paediatric Vaccine in these regions.
This research report categorizes the global Paediatric Vaccine market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter's Five Forces Analysis.
The various contributors involved in the value chain of Paediatric Vaccine include manufacturers, suppliers, distributors, intermediaries, and customers. The key manufacturers in the Paediatric Vaccine include
F. Hoffmann-La Roche
Market Size Split by Type
Allergy and Respiratory vaccines
Other Pediatric vaccines
Market Size Split by Application
Age Above 12
Market size split by Region
Central & South America
Rest of Central & South America
Middle East & Africa
The study objectives of this report are:
To study and analyze the global Paediatric Vaccine market size (value & volume) by company, key regions/countries, products and application, history data from 2013 to 2017, and forecast to 2025.
To understand the structure of Paediatric Vaccine market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Paediatric Vaccine manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Paediatric Vaccine with respect to individual growth trends, future prospects, and their contribution to the total market.
To project the value and volume of Paediatric Vaccine submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
In this study, the years considered to estimate the market size of Paediatric Vaccine are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Paediatric Vaccine market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.